Rilpivirine, sold under the brand name Edurant among others, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz. |
Read full article at Wikipedia
|
InChI=1S/C22H18N6/c1- 15- 12- 18(4- 3- 10- 23) 13- 16(2) 21(15) 27- 20- 9- 11- 25- 22(28- 20) 26- 19- 7- 5- 17(14- 24) 6- 8- 19/h3- 9,11- 13H,1- 2H3,(H2,25,26,27,28) /b4- 3+ |
YIBOMRUWOWDFLG-ONEGZZNKSA-N |
Cc1cc(\C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
A DNA polymerase inhibitor that interferes with the activity of reverse transcriptase, EC 2.7.7.49, a viral DNA polymerase enzyme that retroviruses need in order to reproduce.
HIV-1 reverse transcriptase inhibitor
An entity which inhibits the activity of HIV-1 reverse transcriptase.
|
|
View more via ChEBI Ontology
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
|
4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
|
IUPAC
|
TMC 278
|
ChemIDplus
|
TMC278
|
ChemIDplus
|
500287-72-9
|
CAS Registry Number
|
ChemIDplus
|
500287-72-9
|
CAS Registry Number
|
KEGG DRUG
|
9952270
|
Reaxys Registry Number
|
Reaxys
|
|